The HSD-hCG vaccine prevents pregnancy in women: Feasibility study of a reversible safe contraceptive vaccine

American Journal of Reproductive Immunology

Volumn 37, Issue 2, 1997, Pages 153-160

  Talwar, G P ^a,b   Singh, Om ^a   Gupta, S K ^a   Hasnain, S E ^a   Pal, R ^a   Majumdar, S S ^a   Vrati, S ^a   Mukhopadhay, A ^a   Srinivasan, J ^a   Deshmukh, U ^a   Ganga, S ^a   Mandokhot, A ^a   Gupta, A ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b International Centre of Genetic Engineering and Biotechnology   (India)

Author keywords

Immunodominant epitopes; Post coital tests

Indexed keywords

ALUMINUM HYDROXIDE; ANTIBODY; CHORIONIC GONADOTROPIN BETA SUBUNIT; CONTRACEPTIVE VACCINE; DIPHTHERIA TOXOID; MONOCLONAL ANTIBODY; RECOMBINANT VACCINE; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL TRIAL; CONCEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENDOCRINE FUNCTION; ENZYME IMMUNOASSAY; FAMILY PLANNING; FEASIBILITY STUDY; FEMALE; FEMALE FERTILITY; HEMATOLOGY; HUMAN; IMMUNIZATION; IMMUNOCONTRACEPTION; MENSTRUAL CYCLE; METABOLISM; MULTICENTER STUDY; NONHUMAN; NORMAL HUMAN; OVULATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POSTCOITAL TEST; PREGNANCY; PRIORITY JOURNAL; UTERINE TUBE LIGATION;

EID: 0031040660     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1997.tb00207.x     Document Type: Article

References (26)

1. Birth control vaccines. G.P. Talwar, Raj Raghupathy (ed.), R.G. Landes Company Austin, Texas; Springer-Verlag, Heidelberg, 1995.
2. Talwar GP, Sharma NC, Dubey SK, Salahuddin M. Das C, Ramakrishnan S. Kumar S. Hingorani V. Isoimmunization against human chorionic gonadotropin with conjugates of processed β-subunit of the hormone and tetanus toxoid. Proc Natl Acad Sci USA 1976; 73:218-222.
3. Nash H, Talwar GP, Seagal S, Luukkainen T, Johanson EDB, Vasquez J, Coutinho E, Sundaram K. Observation on anti- genicity and clinical effects of a candidate anti-pregnancy vaccine: β submits of human chorionic gonadotropin linked to tetanus. Fertil Steril 1980; 34:328-335.
4. Stevens VC, Cinader B, Powell JE, Lee AC, Kon SW. Preparation and formulation of a human chorionic gonadotropin antifertility vaccine: Selection of adjuvant and vehicle. Am J Reprod Immunol 1981; 1:315-321.
5. Talwar GP, Om Singh, Rao LV. An improved immunogen for anti-human chorionic gonadotropin vaccine eliciting antibodies reactive with a conformation native to the hormone without crossreaction with human follicle stimulating hormone and human thyroid stimulating hormone. J Reprod Immunol 1988; 14:203-212.
6. Talwar GP, Chaudhuri MK, Jayashankar R. Antigenic derivative of GnRH. Great Britain Patent No. 2228262, 1990.
7. Ladd A, Tsong YY, Lok J, Thau RB. Active immunization against LHRH: I. Effects of conjugation site and dose. Am J Reprod Immunol 1990; 22:56-63.
8. Moudgal NR, Ravindranath N, Murthy GS, Dighe RR, Aravindan GR, Martin F. Long term contraceptive efficacy of vaccine of oFSH in male bonnet monkeys (Macaca radiata). J Reprod Fertil 1992; 96:91-102.
9. Talwar GP, Om Singh, Pal R, Chatterjee N. Vaccines for fertility control and hormone dependent cancers. Int J Immunopharmacol 1992; 14:511-514.
10. Talwar GP, Om Singh, Pal R, Chatterjee N, Sahai P, Dhall K, Kaur J, Das SK, Suri S, Buckshee K, Saraya L, Saxena BN. A vaccine that prevents pregnancy in women. Proc Natl Acad Sci USA 1994; 91:8532-8536.
11. Jones WR, Bradley J, Judd SJ, Denholm EH, Ing RMY, Mueller UW, Powell JH, Griffin PD, Stevens VC. Phase I clinical trial of a World Health Organization birth control vaccine. Lancet 1988; 1:1295-1298.
12. Thau R, Croxatto H, Luukkainen T, Alvarez F, Brache V, Sundaram K, Chang CC, Tsong YY, Zafian P. Advances in the Development of an Antifertility Vaccine. Mettler L, Billington WD (eds). Reproductive Immunology 1989. Elsevier, Amsterdam, 1989, pp. 237-244.
13. Om Singh, Rao LV, Gaur A, Sharma NC, Alam A, Talwar GP. Antibody response and characteristics of antibodies in women immunized with three contraceptive vaccines inducing antibodies against human chorionic gonadotropin. Fertil Steril 1989; 52:739-744.
14. Rose NR, Burek CL and Smith JP. Safety evaluation of hCG vaccine in primates: Autoantibody production. Talwar GP (ed). Contraception research for today and the nineties. Springer-Verlag, New York, 1988, pp. 231-239.
15. Gaur A, Arunan K, Om Singh, Talwar GP. Bypass by an al- ternate carrier of acquired unresponsiveness to hCG upon repeated immunization with tetanus conjugated vaccine. Int Immunol 1990; 2:151-155.
16. Talwar GP, Hingorani V, Kumar S, Roy S, Banerjee A, Shahani SM, Krishna U, Dhall K, Sawhney H, Sharma NC, Om Singh, Gaur A, Rao LV, Arunan K. Phase I clinical trials with three formulations of anti-human chorionic gonadotropin vaccine. Contraception 1990; 41:301-316.
17. Kharat I, Nair NS, Dhall K, Sawhney H, Krishna U, Shahani SM. Banerjee A, Roy S, Kumar S, Hingorani V, Om Singh, Talwar GP. Analysis of menstrual records of women immunized with anti-hCG vaccines inducing antibodies partially cross-reactive with hLH. Contraception 1990; 41:293-299.
18. Deshmukh US, Pal R, Talwar GP, Gupta SK. Antibody response against epitopes on hCG mapped by monoclonal antibodies in women immunized with an anti-hCG vaccine and its implications for bioneutralization. J Reprod Immunol 1993; 25:103-117.
19. Gupta SK, Ramakrishnan S, Talwar GP. Properties and characteristics of an anti-human chorionic gonadotropin monoclonal antibody. J Biosci 1982; 4:105-114.
20. Deshmukh US, Talwar GP, Gupta SK. Antibody response against three epitopic domains on human chorionic gonadotropin (hCG) in women and rodents immunized with a BhCG-based immunocontraceptive vaccine. J Clin Immunol 1994; 14:162-168.
21. Chakrabarti S, Srinivasan J, Lall L, Rao LV, Talwar GP. Expression of biologically active human chorionic gonadotropin and its subunits by recombinant vaccinia virus. Gene 1980; 77:87-93.
22. Mukhopadhyay A, Mukhopadhyay SN, Talwar GP. Studies on the synthesis of β-subunit of chorionic gonadotropin hormone in vero cells by recombinant vaccinia virus. Biotechnol Bioeng 1995; 48:158-168.
23. Mukhopadhyay A, Mukhopadhyay SN, Talwar GP. Physiological factors of growth and susceptibility of virus regulating vero cells for optimum yields of vaccinia and clonal gene product (BhCG). J Biotechnol 1994; 36:177-182.
24. Sridhar P, Panda AK, Pal R, Talwar GP, Hasnain SE. Temporal nature of the promoter and not relative strength determines the expression of an extensively processed protein in a baculovirus system. FEBS Lett 1993; 315:282-285.
25. Krishnan T, Chandrashekar S, Ghorpade AG, Sridhar P, Om Singh, Garg LC, Hasnain SE, Talwar GP. Approaches to Recombinant hCG Birth Control Vaccine. Talwar GP, Rao KVS, Chauhan V (eds). Recombinant and Synthetic Vaccines. Narosa. Springer Verlag, Delhi. 1994, pp. 207-215.
26. Srinivasan J, Om Singh, Chakrabarti S, Talwar GP. Targeting vaccinia virus-expressed secretory β subunit of human chorionic gonadotropin to the cell surface induces antibodies. Infect Immun 1995; 63:4907-4911.